Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Riboflavin kinase pseudogene 2 (RFKP2)
- Target
- RFKP2
- Molecular classification
- Other (Pseudogene)
01
Overview
Riboflavin kinase pseudogene 2 (RFKP2) is a human pseudogene, meaning it is a genomic element that is similar in sequence to the riboflavin kinase gene but is generally considered non-functional and does not produce a protein product. Pseudogenes like RFKP2 do not encode active enzymes or receptors and are not known to play a role in human disease or therapeutic processes[6][8].
- Other names
- RFKP2Riboflavin kinase pseudogene 2
Beyond the preview
Go deeper on Riboflavin kinase pseudogene 2 (RFKP2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Riboflavin kinase pseudogene 2 (RFKP2).